LOCMEDT Debuts at BVC 2026 to Deepen Strategic Cooperation with Korean Clients

BVC 2026 Busan Veterinary Congress concluded successfully at BEXCO Exhibition Centre in South Korea after a two-day event on 29–30 August. Hosted by the Busan Veterinary Medical Association, the Busan Veterinary Congress is a benchmark professional veterinary event across the Asia-Pacific region. Integrating three core segments: continuing clinical education, industrial trade exhibition and global veterinary networking, it stands as South Korea’s largest integrated platform for veterinary academia and commerce. The event serves as a vital hub for the Asia-Pacific veterinary community for academic exchanges, product demonstrations and business channel negotiations.

With years of dedication to the animal healthcare diagnostics sector, LOCMEDT presented its veterinary microfluidic POCT diagnostic solutions at the congress. Beyond product display, our participation aims to build a platform for in-depth communication and cooperation discussions with Korean partners. Together with our partners, we strive to advance the development of LOCMEDT’s industrial ecosystem in the South Korean market.

High-quality channel partnerships are built on robust product strength. LOCMEDT showcased the Noahcali-100 veterinary automatic biochemistry analyzer together with matching lyophilized reagent discs at this event. Powered by self-developed centrifugal microfluidic technology, the instrument requires no complicated supporting equipment or specialized operators. With only a tiny blood sample (90–120 μL), it can deliver diagnostic results rapidly within 8–12 minutes, perfectly catering to the lightweight, high-efficiency and low-cost operation needs of small and medium-sized pet clinics across South Korea. Furthermore, Noahcali-100 supports a total of 51 assay items and enables one-stop detection of up to 43 items. Equipped with an AI-assisted diagnostic system, it effectively improves the professionalism and comprehensiveness of diagnostic outcomes.

During the congress, LOCMEDT booth was continuously visited by Korean customers for inquiries and business discussions. Customers operated and tested the devices on-site, compared assay performance, and gained an in-depth understanding of the technical advantages of LOCMEDT products. They widely recognized LOCMEDT’s differentiated competitiveness and promising market potential in South Korea’s end-user market. Leveraging this exhibition platform, LOCMEDT successfully connected with multiple prospective channel partners, laying a solid foundation for subsequent regional exclusive cooperation, channel distribution and market empowerment.

At this congress, LOCMEDT fully demonstrated its brand strength and accelerated the improvement of channel partnership layout across South Korea. We will continue to gather high-quality channel resources and deepen strategic cooperation with clients. With reliable veterinary diagnostic products, we will work alongside partners to jointly explore the pet medical diagnostics market.